Taysha Gene Therapies TSHA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 5.50 | 101.66 | -0.08 | -28,300 | -28 | |
| 2025Q3 | 3.27 | 103.99 | -0.09 | -34,024 | -33 | |
| 2025Q2 | 2.31 | 99.58 | -0.09 | -26,753 | -27 | |
| 2025Q1 | 1.39 | 99.59 | -0.08 | -21,421 | -22 | |
| 2024Q4 | 1.73 | 106.23 | -0.07 | -19,932 | -19 | |
| 2024Q3 | 2.01 | 101.56 | -0.10 | -25,898 | -26 | |
| 2024Q2 | 2.24 | 101.90 | -0.09 | -21,299 | -21 | |
| 2024Q1 | 2.87 | 101.24 | -0.10 | -24,330 | -24 | |
| 2023Q4 | 1.77 | -33.53 | 0.92 | -16,246 | 48 | |
| 2023Q3 | 3.16 | 14.06 | -1.22 | -16,250 | -117 | |
| 2023Q2 | 0.66 | 100.98 | -0.38 | -23,384 | -25 | |
| 2023Q1 | 0.80 | 101.91 | -0.28 | -16,559 | -18 | |
| 2022Q4 | 2.26 | 100.36 | -0.99 | -53,966 | -55 | |
| 2022Q3 | 1.93 | 100.03 | -0.63 | -24,303 | -26 | |
| 2022Q2 | 3.72 | 100.07 | -0.84 | -32,602 | -34 | |
| 2022Q1 | 6.52 | 100.01 | -1.32 | -49,268 | -50 | |
| 2021Q4 | 11.65 | 100.06 | -1.33 | -49,724 | -50 | |
| 2021Q3 | 18.62 | 100.07 | -1.35 | -50,681 | -51 | |
| 2021Q2 | 21.20 | 100.10 | -1.09 | -40,772 | -41 | |
| 2021Q1 | 20.30 | 100.21 | -0.87 | -32,090 | -32 |